Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
Cellares has just closed a major $255 million third-round financing that will be used to complete a highly automated facility in New Jersey for the production of cell therapies. The Series C takes the ...
All times are UK and subject to change. BBC is not responsible for any changes. Copyright © 2026 BBC. The BBC is not responsible for the content of external sites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results